pubrio
齐鲁制药有限公司

齐鲁制药有限公司

China · Pharmaceutical Manufacturing

Research

Pharmaceuticals

Healthcare

Pharmaceutical Manufacturing

齐鲁制药集团主要从事肿瘤、心脑血管、感染、精神系统、神经系统、眼科疾病的制剂及原料药的研制、生产与销售。下设13家子公司,员工23000余人。2019年度,实现销售收入251亿元,上交税金23亿元,实现出口6.15亿美元;位列2018年度中国医药工业百强榜第8位。 齐鲁制药始终坚持创新驱动战略,建立了中美联动五大研发平台,专职研发人员2000余人。每年销售收入的6%以上投入研发。在研创新药物项目合计50余项。在精准靶向治疗、免疫治疗、细胞治疗和新型给药系统等领域全面布局,持续抢占国际药物研发新高地。

Company Insights
Company Overview

1998

Founded

Pharmaceutical Manufacturing

Industry

China

Location

17,782,079

Ranking

1,800 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding 齐鲁制药有限公司

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​